Temps Différé
Autres places de cotation
|
Varia. 5j. | Varia. 1 janv. | ||
1 521 INR | +2,40 % | +0,33 % | +20,80 % |
Métier
- médicaments génériques et OTC (94%) : destinés au traitement des maladies cardiologiques, psychiatriques, neurologiques, gastroentérologiques, diabétiques et respiratoires ;
- autres (6%) : notamment ingrédients pharmaceutiques actifs.
A fin mars 2021, le groupe dispose de 44 sites de production dans le monde.
La répartition géographique du CA est la suivante : Inde (33%), Etats-Unis (31,3%), autres (35,7%).
Nombre d'employés: 41 000
Ventes par activité
INR en Millions | 2022 | Poids | 2023 | Poids | Delta |
---|---|---|---|---|---|
Pharmaceutical
100,0
%
| 384 264 | 100,0 % | 432 789 | 100,0 % | +12,63 % |
Ventes par région
INR en Millions | 2022 | Poids | 2023 | Poids | Delta |
---|---|---|---|---|---|
India
32,7
%
| 134 439 | 35,0 % | 141 624 | 32,7 % | +5,34 % |
United States
32,3
%
| 117 344 | 30,5 % | 139 704 | 32,3 % | +19,06 % |
Emerging Markets
19,8
%
| 72 757 | 18,9 % | 85 633 | 19,8 % | +17,70 % |
Rest of the World
15,2
%
| 59 726 | 15,5 % | 65 827 | 15,2 % | +10,22 % |
Dirigeants
Dirigeants | Titre | Age | Depuis |
---|---|---|---|
Aalok Shanghvi
CEO | Chief Executive Officer | - | - |
Founder | 68 | 01/01/82 | |
Director of Finance/CFO | - | 19/06/17 | |
Anil Rao
CTO | Chief Tech/Sci/R&D Officer | - | 01/06/22 |
Anoop Deshpande
CMP | Compliance Officer | - | 01/04/21 |
Nimish Desai
IRC | Investor Relations Contact | - | - |
Suresh Kumar Rai
HRO | Human Resources Officer | - | 07/12 |
S. Damodharan
PRN | Corporate Officer/Principal | - | - |
Abhay Gandhi
PRN | Corporate Officer/Principal | 59 | 01/04/07 |
Corporate Officer/Principal | 65 | - |
Administrateurs
Administrateurs | Titre | Age | Depuis |
---|---|---|---|
Founder | 68 | 01/01/82 | |
Rama Bijapurkar
BRD | Director/Board Member | 67 | 21/05/21 |
Rolf K. Hoffmann
BRD | Director/Board Member | 63 | 15/06/23 |
Aalok Shanghvi
BRD | Director/Board Member | - | - |
Director/Board Member | 67 | 01/01/94 | |
Director/Board Member | 60 | 01/11/22 | |
Director/Board Member | 71 | 25/05/18 | |
Director/Board Member | 68 | 21/05/21 | |
Abhay Gandhi
PRN | Corporate Officer/Principal | 59 | 01/04/07 |
Classe d'actions
Vote | Nombre | Flottant | Autocontrôle | Flottant Total | |
---|---|---|---|---|---|
Action A | 1 | 2 399 334 970 | 1 087 065 568 ( 45,31 %) | 0 | 45,31 % |
Participations
Nom | Actions | % | Valorisation |
---|---|---|---|
29 497 813 | 78,48% | 1 248 937 402 $ | |
SCPHARMACEUTICALS INC. 6,01% | 2 167 679 | 6,01% | 10 881 749 $ |
Coordonnées société
Sun Pharmaceutical Industries Ltd.
CTS No. 201 B/1, Sun House Western Express Highway
400063, Mumbai
+91 22 4324 4324
http://www.sunpharma.comSociétés du groupe
Nom | Catégorie et Secteur |
---|---|
Basics GmbH
Basics GmbH Medical DistributorsDistribution Services Part of Sun Pharmaceutical Industries Ltd., Basics GmbH is a pharmaceutical company based in Leverkusen, DE. The CEO of the private company is Hellen de Kloet. The German company distributes high-quality and medically recognized prescription drugs, covering a wide range of therapeutic indications with their generics. For more information, healthcare professionals can log in with their access data on the company's website. The company's contact information is available on their website for customer service and orders. |
Medical Distributors
|
Sun Pharma (Netherlands) BV
Sun Pharma (Netherlands) BV Drugstore ChainsRetail Trade Sun Pharma (Netherlands) BV engages in the sale and distribution of generic medicine. The company is headquartered in Hoofddorp, the Netherlands. |
Drugstore Chains
|
Sun Pharma Distributors Ltd.
| |
Sun Pharma Laboratories Ltd.
Sun Pharma Laboratories Ltd. Pharmaceuticals: MajorHealth Technology Sun Pharma Laboratories Ltd. operates as a pharmaceutical company. The company is headquartered in Mumbai, India. |
Pharmaceuticals: Major
|
Secteur
Ventes par région
Révisions de BNA
Varia. 1 janv. | Capi. | |
---|---|---|
+19,43 % | 42,78 Md | |
+18,59 % | 22,25 Md | |
+13,30 % | 14,39 Md | |
+11,87 % | 13,55 Md | |
+35,24 % | 11,27 Md | |
-9,80 % | 6,95 Md | |
-0,05 % | 6,79 Md | |
-8,87 % | 5,73 Md | |
+6,29 % | 5,01 Md | |
-8,24 % | 4,51 Md |
- Bourse
- Actions
- Action SUNPHARMA
- Société Sun Pharmaceutical Industries Ltd.